Discontinued — last reported Q4 '25
EPS (Diluted)
Earnings Per ShareJohnson & Johnson EPS (Diluted) decreased by 7.4% to $2.12 in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 91.0%, from $1.11 to $2.12. Over 3 years (FY 2021 to FY 2024), EPS (Diluted) shows relatively stable performance with a -1.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
A narrowing gap between basic and diluted EPS suggests less potential for future shareholder dilution.
Detailed definition
A performance metric that calculates earnings per share by assuming all convertible securities, such as stock options an...
Peer comparison
In the technology sector, where stock-based compensation is prevalent, this is often considered the more accurate reflection of shareholder value than basic EPS.
is_eps_dilutedHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.32 | $2.35 | $1.37 | $1.32 | $1.93 | $1.80 | $1.68 | $10.12 | -$0.03 | $1.96 | $1.67 | $1.34 | $1.93 | $1.11 | $1.41 | $4.54 | $2.29 | $2.12 |
| QoQ Change | — | +1.3% | -41.7% | -3.6% | +46.2% | -6.7% | -6.7% | +502.4% | -100.3% | >999% | -14.8% | -19.8% | +44.0% | -42.5% | +27.0% | +222.0% | -49.6% | -7.4% |
| YoY Change | — | — | — | — | -16.8% | -23.4% | +22.6% | +666.7% | -101.6% | +8.9% | -0.6% | -86.8% | >999% | -43.4% | -15.6% | +238.8% | +18.7% | +91.0% |
EPS (Diluted) at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's eps (diluted)?
- Johnson & Johnson (JNJ) reported eps (diluted) of $2.12 in Q3 2025.
- How has Johnson & Johnson's eps (diluted) changed year-over-year?
- Johnson & Johnson's eps (diluted) increased by 91.0% year-over-year, from $1.11 to $2.12.
- What is the long-term trend for Johnson & Johnson's eps (diluted)?
- Over 3 years (2021 to 2024), Johnson & Johnson's eps (diluted) has grown at a -1.4% compound annual growth rate (CAGR), from $6.04 to $5.79.
- What does eps (diluted) mean?
- The amount of profit per share if all possible stock options and convertible bonds were turned into actual shares.